An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and relates to the scope to be accorded to patent claims, including the doctrine of equivalents. The case and subsequent judgment affirmed principles from a prior case, Catnic Components Ltd. v. Hill & Smith Ltd.

Property Value
dbo:abstract
  • Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and relates to the scope to be accorded to patent claims, including the doctrine of equivalents. The case and subsequent judgment affirmed principles from a prior case, Catnic Components Ltd. v. Hill & Smith Ltd. The issue was whether the claims of a European patent granted to Kirin-Amgen, Inc. were infringed by Transkaryotic Therapies Inc. and Hoechst Marion Roussel Ltd in a situation where there was a remarkable similarity between the technologies employed by the two parties for producing the hormone erythropoietin. Infringement was not found due to the language used in the claims of the Amgen patent. The reasoning in the judgment has presently formed a basis for the current practice of the UK Intellectual Property Office, and other countries that take great consideration of the legal implications of British case law when assessing whether a patent has been infringed by a device or process which is equivalent to the patented invention. (See also Doctrine of equivalents.) (en)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 14351738 (xsd:integer)
dbo:wikiPageLength
  • 18949 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082950567 (xsd:integer)
dbo:wikiPageWikiLink
dbp:citations
  • [2004] UKHL 46 (en)
dbp:fullName
  • Kirin-Amgen Inc and others v. Hoechst Marion Roussel Limited and others . Kirin-Amgen Inc and others v. Hoechst Marion Roussel Limited and others (en)
dbp:judges
dbp:name
  • Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd (en)
dbp:transcripts
dbp:wikiPageUsesTemplate
dcterms:subject
rdfs:comment
  • Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and relates to the scope to be accorded to patent claims, including the doctrine of equivalents. The case and subsequent judgment affirmed principles from a prior case, Catnic Components Ltd. v. Hill & Smith Ltd. (en)
rdfs:label
  • Kirin-Amgen Inc v Hoechst Marion Roussel Ltd (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License